A Study of Tirbanibulin Ointment and Diclofenac Sodium Gel for the Treatment of Adult Participants With Actinic Keratosis on the Face or Scalp

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

447

Participants

Timeline

Start Date

October 24, 2022

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2027

Conditions
Keratosis, Actinic
Interventions
DRUG

Tirbanibulin (Klisyri®) 10 mg/g ointment

Participants will apply tirbanibulin 10 mg/g ointment topically for 5 days over 25 cm\^2 of the face or scalp with Actinic Keratosis (AK).

DRUG

Diclofenac Sodium 3% Gel

Participants will apply diclofenac dodium 3% gel twice daily for 60 to 90 days.

Trial Locations (49)

Unknown

Almirall Investigation Site 102, Lille

Almirall Investigation Site 103, Marseille

Almirall Investigation Site 104, Nice

Almirall Investigational Site 106, Paris

Almirall Investigational Site 105, Rouen

Almirall Investigational Site 101, Saint-Priest-en-Jarez

Almirall Investigational Site 205, Augsburg

Almirall Investigational Site 211, Bad Bentheim

Almirall Investigation Site 201, Bochum

Almirall Investigational Site 214, Bochum

Almirall Investigational Site 212, Bonn

Almirall Investigational Site 208, Detmold

Almirall Investigational Site 210, Dresden

Almirall Investigational Site 204, Erlangen

Almirall Investigational Site 206, Hamburg

Almirall Investigational Site 213, Hamburg

Almirall Investigational Site 207, Marburg

Almirall Investigational Site 209, Merzig

Almirall Investigation Site 202, Recklinghausen

Almirall Investigational Site 309, Arezzo

Almirall Investigational Site 302, Brescia

Almirall Investigational Site 304, Genova

Almirall Investigational Site 308, Modena

Almirall Investigational Site 301, Napoli

Almirall Investigational Site 303, Reggio Emilia

Almirall Investigational Site 305, Roma

Almirall Investigational Site 306, Roma

Almirall Investigational Site 307, Roma

Almirall Investigational Site 310, Rozzano

Almirall Investigational Site 403, Lublin

Almirall Investigational Site 406, Rzeszów

Almirall Investigational Site 407, Warsaw

Almirall Investigational Site 401, Wroclaw

Almirall Investigational Site 402, Wroclaw

Almirall Investigational Site 502, Barcelona

Almirall Investigational Site 508, Barcelona

Almirall Investigational Site 510, Barcelona

Almirall Investigational Site 507, Granada

Almirall Investigational Site 509, Granada

Almirall Investigational Site 503, Madrid

Almirall Investigational Site 504, Salamanca

Almirall Investigational Site 505, Seville

Almirall Investigational Site 506, Valencia

Almirall Investigational Site 501, Zaragoza

Almirall Investigational Site 703, London

Almirall Investigational Site 709, London

Almirall Investigational Site 708, Oxford

Almirall Investigational Site 704, Poole

Almirall Investigational Site 706, Weston-super-Mare

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Almirall, S.A.

INDUSTRY

NCT05387525 - A Study of Tirbanibulin Ointment and Diclofenac Sodium Gel for the Treatment of Adult Participants With Actinic Keratosis on the Face or Scalp | Biotech Hunter | Biotech Hunter